Arcutis Biotherapeutics, Inc. (ARQT) Reports Q2 Loss, Beats Revenue Estimates

Arcutis Biotherapeutics, Inc. (ARQT) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of$ 0.18. This compares to a loss of $0.42 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +27.78%. A quarter ago, it was expected that this company would post a loss of$ 0.21 per share when it actually produced a loss of $0.2, delivering a surprise of +4.76%.Over the last four quarters, the comp ...